Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 11, 2012 | December 13, 2012 |
| AbbVie Inc.ABBV · Entity 2800 | Vice Chairman | February 25, 2022 | March 01, 2022 |
| CrowdStrike Holdings, Inc.CRWD · Entity 1172 | Director | September 18, 2026 | September 22, 2026 |
| GENERAL DYNAMICS CORPGD · Entity 2916 | Director | September 16, 2026 | September 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 11, 2012 · Filed December 13, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 179,338 |
Ending reported balance
After 2012-12-11 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2012-12-11 · Exercise / conversion · Acquired 36,985 · Balance 216,323 Row 2 · 2012-12-11 · Exercise / conversion · Acquired 67,200 · Balance 283,523 Row 3 · 2012-12-11 · Exercise / conversion · Acquired 1,045 · Balance 284,568 Row 4 · 2012-12-11 · Exercise / conversion · Acquired 2,395 · Balance 286,963 Row 5 · 2012-12-11 · Exercise / conversion · Acquired 652 · Balance 287,615 Row 6 · 2012-12-11 · Exercise / conversion · Acquired 11,500 · Balance 299,115 Row 7 · 2012-12-11 · Sale · Disposed 119,777 · Balance 179,338 |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.34 · Expires 2015-02-17 | Direct | 0 |
Reported balance
After 2012-12-11 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2012-12-11 · Exercise / conversion · Disposed 36,985 · Balance 0 F1: Employee stock option granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.54 · Expires 2017-02-15 | Direct | 0 |
Reported balance
After 2012-12-11 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2012-12-11 · Exercise / conversion · Disposed 67,200 · Balance 0 F1: Employee stock option granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.16 · Expires 2013-02-13 | Direct | 0 |
Reported balance
After 2012-12-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2012-12-11 · Exercise / conversion · Disposed 1,045 · Balance 0 F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.74 · Expires 2014-02-19 | Direct | 0 |
Reported balance
After 2012-12-11 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2012-12-11 · Exercise / conversion · Disposed 2,395 · Balance 0 F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.01 · Expires 2013-02-13 | Direct | 0 |
Reported balance
After 2012-12-11 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2012-12-11 · Exercise / conversion · Disposed 652 · Balance 0 F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.60 · Expires 2021-02-17 | Direct | 38,333 |
Reported balance
After 2012-12-11 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2012-12-11 · Exercise / conversion · Disposed 11,500 · Balance 38,333 F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: Employee stock option granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3.
F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.
F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
AbbVie Inc.
Report date February 25, 2022 · Filed March 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 248,002 |
Reported balance
After 2022-02-25 transaction · row 1
1 source rowRow 1 · 2022-02-25 · Tax withholding · Disposed 40,490 · Balance 248,002 |
CrowdStrike Holdings, Inc.
Report date September 18, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | Direct | 38,724 |
Reported balance
After 2026-09-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-18 · Grant · Acquired 68 · Balance 38,724 F1: The shares represent fully vested RSUs issued in lieu of quarterly cash retainer(s) payable under the issuer's Outsider Director Compensation Policy. The RSUs immediately converted into shares of the issuer's Class A Common Stock. F2: On July 2, 2026, the Issuer executed a four-for-one stock split with a record date of June 25, 2026, effected in the form of a one-time special stock dividend on each share of the company's Class A common stock. F3: Includes shares to be issued in connection with the vesting of one or more RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares represent fully vested RSUs issued in lieu of quarterly cash retainer(s) payable under the issuer's Outsider Director Compensation Policy. The RSUs immediately converted into shares of the issuer's Class A Common Stock.
F2: On July 2, 2026, the Issuer executed a four-for-one stock split with a record date of June 25, 2026, effected in the form of a one-time special stock dividend on each share of the company's Class A common stock.
F3: Includes shares to be issued in connection with the vesting of one or more RSUs.
GENERAL DYNAMICS CORP
Report date September 16, 2026 · Filed September 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,792 |
Reported balance
After 2026-09-16 transaction · row 1
1 source rowRow 1 · 2026-09-16 · Grant · Acquired 105 · Balance 13,792 F1: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2023 Filed Mar 9, 2023 22:15 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017600 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,204 F1 · kind: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:19 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 107 | $231.97 | $24,820.79 |
DisclosureSEC source: 0001209191-23-017196 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,829 F1 · kind: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:29 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 127 | $245.39 | $31,164.53 |
DisclosureSEC source: 0001209191-22-062161 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,936 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 20:21 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 136 | $229.00 | $31,144.00 |
DisclosureSEC source: 0001209191-22-050721 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,809 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| June 29, 2022 Filed Jul 2, 2022 00:37 UTC | CrowdStrike Holdings, Inc. CRWD · Entity 1172 | GrantClass A common stock | 1,307 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-011920 · dp176612_4-schumacher.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,738 F1 · shares: The shares represent unvested restricted stock units ("RSUs"), with the RSUs vesting in full on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders held after the date of grant. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 15:28 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 143 | $218.01 | $31,175.43 |
DisclosureSEC source: 0001209191-22-038300 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,673 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| March 16, 2022 Filed Mar 17, 2022 20:39 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 132 | $235.91 | $31,140.12 |
DisclosureSEC source: 0001209191-22-019612 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,530 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:24 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 98 | $250.24 | $24,523.52 |
DisclosureSEC source: 0001209191-22-017581 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,398 F1 · kind: Represents the withholding of shares of Common Stock under the General Dynamics Corporation equity compensation plan to satisfy tax withholding obligations in connection with the release of restricted shares. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:42 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 2,190 | $0.00 Strike: $232.90 | $0.00 |
DisclosureSEC source: 0001209191-22-016302 · doc4.xml · derivative · entry 2 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,190 Underlying: Common Stock · 2,190 shares Expires 2032-03-01 F2 · derivative.exercise_date: Fifty percent become exercisable on 03/02/2024 and the remaining fifty percent become exercisable on 03/02/2025. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:42 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016302 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,496 F1 · kind: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon Stock, $0.01 par value | 40,490 | $149.54 | $6,054,874.60 |
DisclosureSEC source: 0001179110-22-001826 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,002 Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:33 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (Right to Buy) · Derivative | 56,917 | $0.00 Strike: $144.54 | $0.00 |
DisclosureSEC source: 0001179110-22-001508 · edgar.xml · derivative · entry 5 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,917 Underlying: Common Stock · 56,917 shares Expires 2032-02-16 F5 · security: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,973 on February 17, 2023, 18,972 on February 17, 2024, and 18,972 on February 17, 2025. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:33 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 11,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001508 · edgar.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,492 F4 · shares: Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:33 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 17,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001508 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,927 F3 · shares: Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:33 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 11,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001508 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,459 F2 · shares: Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:33 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 51,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001508 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,323 F1 · shares: Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 22:01 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon Stock, $0.01 par value | 15,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-011230 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,098 Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (Right To Buy) · Derivative | 78,450 | $54.86 Strike: $0.00 | $4,303,767.00 |
DisclosureSEC source: 0001179110-21-011172 · edgar.xml · derivative · entry 6 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 78,450 shares Expires 2026-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (Right To Buy) · Derivative | 103,220 | $58.88 Strike: $0.00 | $6,077,593.60 |
DisclosureSEC source: 0001179110-21-011172 · edgar.xml · derivative · entry 5 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 103,220 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon Stock, $0.01 par value | 4,114 | $130.61 | $537,329.13 |
DisclosureSEC source: 0001179110-21-011172 · edgar.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,003 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.56 to $131.09, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon Stock, $0.01 par value | 177,556 | $130.23 | $23,123,348.70 |
DisclosureSEC source: 0001179110-21-011172 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,117 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.56 to $130.55, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon Stock, $0.01 par value | 78,450 | $54.86 | $4,303,767.00 |
DisclosureSEC source: 0001179110-21-011172 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 22:21 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon Stock, $0.01 par value | 103,220 | $58.88 | $6,077,593.60 |
DisclosureSEC source: 0001179110-21-011172 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 21:08 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 115 | $204.85 | $23,557.75 |
DisclosureSEC source: 0001209191-21-070550 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,131 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 19:23 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 120 | $197.77 | $23,732.40 |
DisclosureSEC source: 0001209191-21-056842 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,016 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| September 01, 2021 Filed Sep 10, 2021 21:02 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon Stock, $0.01 par value | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008721 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,003 Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 21:54 UTC | CrowdStrike Holdings, Inc. CRWD · Entity 1172 | GrantClass A common stock | 795 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-010062 · dp153873_4-schumacher.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,431 F1 · shares: The shares represent unvested restricted stock units ("RSUs"), with the RSUs vesting in full on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders held after the date of grant. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 16:32 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 123 | $192.15 | $23,634.45 |
DisclosureSEC source: 0001209191-21-041886 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,896 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 18:35 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 135 | $175.48 | $23,689.80 |
DisclosureSEC source: 0001209191-21-021731 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,773 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 14:18 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 2,770 | $0.00 Strike: $168.56 | $0.00 |
DisclosureSEC source: 0001209191-21-018073 · doc4.xml · derivative · entry 2 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,770 Underlying: Common Stock · 2,770 shares Expires 2031-03-02 F2 · derivative.exercise_date: Fifty percent become exercisable on 03/03/2023 and the remaining fifty percent become exercisable on 03/03/2024. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 14:18 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018073 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,638 F1 · kind: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
| February 28, 2021 Filed Mar 3, 2021 01:25 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon Stock, $0.01 par value | 29,203 | $107.74 | $3,146,331.22 |
DisclosureSEC source: 0001179110-21-002589 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,253 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 23:19 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption(right to buy) · Derivative | 65,217 | $0.00 Strike: $105.92 | $0.00 |
DisclosureSEC source: 0001179110-21-002047 · edgar.xml · derivative · entry 5 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,217 Underlying: Common stock · 65,217 shares Expires 2031-02-17 F5 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 21,739 on February 18, 2022 21,739 on February 18, 2023, and 21,739 on February 18, 2024. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 23:19 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 17,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002047 · edgar.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,456 F4 · shares: Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 23:19 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 11,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002047 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,988 F3 · shares: Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 23:19 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 8,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002047 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,852 F2 · shares: Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 23:19 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 28,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002047 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,373 F1 · shares: . Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021. Read SEC document |
| December 23, 2020 Filed Dec 31, 2020 18:14 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon Stock, $0.01 par value | 28,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-012332 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,541 Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:57 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionStock Options · Derivative | 4,400 | $0.00 Strike: $112.40 | $0.00 |
DisclosureSEC source: 0001209191-20-064103 · doc4.xml · derivative · entry 4 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,400 shares Expires 2021-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fifty percent became exercisable on 03/05/2015 and the remaining fifty percent became exercisable on 03/05/2016. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:57 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Tax withholdingCommon Stock | 3,477 | $153.66 | $534,275.82 |
DisclosureSEC source: 0001209191-20-064103 · doc4.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,163 Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:57 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | Exercise / conversionCommon Stock | 4,400 | $112.40 | $494,560.00 |
DisclosureSEC source: 0001209191-20-064103 · doc4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:57 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 154 | $153.72 | $23,672.88 |
DisclosureSEC source: 0001209191-20-064103 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,240 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| November 30, 2020 Filed Dec 3, 2020 01:03 UTC | CrowdStrike Holdings, Inc. CRWD · Entity 1172 | GrantClass A common stock | 1,190 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-20-023663 · dp142344_4-schumacher.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,636 F3 · shares: The shares represent unvested RSUs with the RSUs vesting in full on the earlier of (i) July 6, 2021 or (ii) the date of the Issuer's next annual meeting of stockholders held after the date of grant. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| November 30, 2020 Filed Dec 3, 2020 01:03 UTC | CrowdStrike Holdings, Inc. CRWD · Entity 1172 | GrantClass A common stock | 2,446 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-20-023663 · dp142344_4-schumacher.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,446 F1 · shares: The shares represent unvested restricted stock units ("RSUs"), with the RSUs vesting in equal installments on the first three anniversaries of the date of grant. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 20:25 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 162 | $146.54 | $23,739.48 |
DisclosureSEC source: 0001209191-20-050900 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,086 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 15:29 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 158 | $149.50 | $23,621.00 |
DisclosureSEC source: 0001209191-20-037513 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,924 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| April 02, 2020 Filed Apr 24, 2020 21:08 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon Stock, $0.01 par value | 410 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-005098 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,491 Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 14:28 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 180 | $131.68 | $23,702.40 |
DisclosureSEC source: 0001209191-20-019909 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,766 F1 · kind: Reflects stock received in lieu of director fees in accordance with outside directors' compensation program. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 19:41 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantStock Options · Derivative | 3,210 | $0.00 Strike: $165.47 | $0.00 |
DisclosureSEC source: 0001209191-20-016516 · doc4.xml · derivative · entry 2 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,210 Underlying: Common Stock · 3,210 shares Expires 2030-03-03 F2 · derivative.exercise_date: Fifty percent become exercisable on 03/04/2022 and the remaining fifty percent become exercisable on 03/04/2023. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 19:41 UTC | GENERAL DYNAMICS CORP GD · Entity 2916 | GrantCommon Stock | 485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016516 · doc4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,586 F1 · kind: Represents shares of restricted stock subject to service-based vesting that will be released three years after the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.